Nuclear Receptor 4A1 (NR4A1) and NR4A2 Regulate Expression of O6-Methylguanine-DNA-Methyltransferase (MGMT) in Glioblastoma and Can Be Targeted by NR4A1/2 Ligands
Purpose Glioblastoma (GBM) is highly malignant and aggressive with limited treatment options. Resistance to the standard of care temozolomide (TMZ) is associated with expression of O 6 -methylguanine-DNA-methyltransferase (MGMT). This study investigates whether orphan nuclear receptor 4A1 (NR4A1) and NR4A2 regulate MGMT expression in GBM cells and whether DIM-3,5 compounds decrease MGMT expression and could be used to enhance TMZ efficacy in GBM cells. Methods Human and mouse GBM cell lines were used. Cells were treated with DIM-3,5 compounds and TMZ to evaluate cell proliferation. RNA interference was used to knockdown NR4A1/2, Sp1, or MGMT. MGMT mRNA and protein expression was measured using qrt-PCR and Western blotting. Luciferase reporter assays examined MGMT promoter activity, while chromatin immunoprecipitation (ChIP) assays investigated transcription factor interactions on the MGMT promoter. Results DIM-3,5 compounds significantly decreased GBM cell proliferation in all cell lines. DIM-3,5 compounds or knockdown of NR4A1/2 or Sp1 significantly decreased MGMT mRNA, protein, and luciferase promoter expression in all cell lines. ChIP analysis demonstrated that NR4A1 and NR4A2 regulate MGMT through interactions with a NBRE motif and Sp1 regulates MGMT through GC-rich promoter regions. Additionally, MGMT knockdown increased TMZ-induced cytotoxicity in GBM cells. Conclusion This study shows that NR4A1/2/Sp1 are involved in MGMT regulation through complex mechanisms that include regulation by Sp1 alone and by direct interaction of NR4A1 and NR4A2 as monomers with an NBRE motif. DIM-3,5 ligands act as inverse NR4A1/2 agonists and downregulate MGMT expression in GBM cells.
Authors
- Srijana Upadhyay (ORCID: https://orcid.org/0000-0001-5236-3485)
- Wai Ning Tiffany Tsui (ORCID: https://orcid.org/0009-0004-0763-7458)
- Karol Bomsztyk (ORCID: https://orcid.org/0000-0002-9169-7573)
- Daniel Mar
- Arafat Rahman Oany (ORCID: https://orcid.org/0000-0003-2228-457X)
- Gargi Sivaram (ORCID: https://orcid.org/0000-0003-4278-7019)
- Svetlana A. Mikheeva
- Evan Farkas (ORCID: https://orcid.org/0009-0006-2724-5667)
- Stephen Safe
- Ana Gutierrez
- Andrei Mikheev
- Robert Rostomily
- Sofia Melgoza
Institutions
- Houston Methodist (US)
- University of Washington (US)
- Houston Methodist Research Institute (US)
- Texas A&M University (US)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-20
- DOI
- https://doi.org/10.21203/rs.3.rs-11627997/v1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- preprint
Funders
- National Institutes of Health